The estimated Net Worth of Falko Busse is at least $4.85 Milión dollars as of 28 February 2024. Falko Busse owns over 28,122 units of Bruker Corp stock worth over $3,902,174 and over the last 6 years he sold BRKR stock worth over $0. In addition, he makes $950,030 as President a Bruker BioSpin Group at Bruker Corp.
Sign up
Falko Busse BRKR stock SEC Form 4 insiders trading
Falko has made over 1 trades of the Bruker Corp stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 28,122 units of BRKR stock worth $739,046 on 28 February 2024.
The largest trade he's ever made was exercising 28,122 units of Bruker Corp stock on 28 February 2024 worth over $739,046. On average, Falko trades about 3,515 units every 0 days since 2018. As of 28 February 2024 he still owns at least 60,981 units of Bruker Corp stock.
You can see the complete history of Falko Busse stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Falko Busse biography
Dr. Falko Busse Ph.D. serves as President, Bruker BioSpin Group of the Company. Dr. Busse has served as President of the Bruker BioSpin Group since May 2018, with responsibility for management of its global operations. Dr. Busse served as Deputy President of the Bruker BioSpin Group from October 2017 until his appointment as President. From March 2017 to September 2017, Dr. Busse served as Executive Vice President of Research and Development, Operations and Marketing at the Bruker BioSpin Group. Dr. Busse joined the Bruker BioSpin Group in June 2015 and served as Executive Vice President of Research and Development until February 2017. Prior to joining the Bruker BioSpin Group, Dr. Busse served in various managerial roles at Philips Healthcare and its subsidiaries from August 1994 until May 2015, including as General Manager Radiology Solutions, from January 2014 to May 2015, and as General Manager MR-Therapy, from August 2009 to December 2013. Dr. Busse holds a B.A. and a Ph.D. in Physics from Rheinische Friedrich-Wilhelms-Universität Bonn.
What is the salary of Falko Busse?
As the President a Bruker BioSpin Group of Bruker Corp, the total compensation of Falko Busse at Bruker Corp is $950,030. There are 6 executives at Bruker Corp getting paid more, with Frank Laukien having the highest compensation of $4,909,640.
How old is Falko Busse?
Falko Busse is 53, he's been the President a Bruker BioSpin Group of Bruker Corp since 2018. There are 20 older and 1 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
What's Falko Busse's mailing address?
Falko's mailing address filed with the SEC is 40, Manning Road, Billerica, Middlesex County, Massachusetts, 01821, United States.
Insiders trading at Bruker Corp
Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien a Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.
What does Bruker Corp do?
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
What does Bruker Corp's logo look like?
Complete history of Falko Busse stock trades at Bruker Corp
Bruker Corp executives and stock owners
Bruker Corp executives and other stock owners filed with the SEC include:
-
Frank Laukien,
Chairman of the Board, President, Chief Executive Officer -
Mark Munch,
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division -
Juergen Srega,
President of Bruker CALID Group and Bruker Daltonics Division -
Gerald Herman,
Chief Financial Officer -
Dr. Frank H. Laukien Ph.D.,
Chairman, CEO & Pres -
Burkhard Prause,
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc -
Falko Busse,
President, Bruker BioSpin Group -
Dr. Mark R. Munch Ph.D.,
Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division -
Juergen Srega,
Pres of Bruker CALID Group & Bruker Daltonics Division -
Gerald N. Herman,
Exec. VP, CFO, Corp. Controller & Interim Head of IR -
Dr. Falko Busse Ph.D.,
Pres of Bruker BioSpin Group -
John Ornell,
Independent Director -
Richard Packer,
Independent Director -
Robert Rosenthal,
Independent Director -
Adelene Perkins,
Independent Director -
William Linton,
Lead Independent Director -
Marc Kastner,
Independent Director -
Hermann Requardt,
Independent Director -
Cynthia Friend,
Independent Director -
Miroslava Minkova,
Director, Investor Relations & Corporate Development -
Bonnie Anderson,
Independent Director -
J. Brent Alldredge J.D.,
Gen. Counsel -
Justin Joseph Ward,
Sr. Director of Investor Relations & Corp. Devel. -
Kristin S. Caplice,
Sec. -
Dr. Burkhard Prause,
Pres and CEO of Bruker Energy & Supercon Technologies, Inc. -
Urban Faeh,
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH -
Stacey Desrochers,
Treasurer & Director of Investor Relations -
Collin J. D'Silva,
Pres of Chemical Analysis Division -
M Christopher Canavan,
Director -
Richard Kniss,
Director -
Ingen Chris Van,
Director -
Stephen W. Fesik,
Director -
Rene Lenggenhager,
President, BioSpin Group -
Anthony L Mattacchione,
Sr VP, Corp Fin & Accounting -
Gilles Gerard Jean Martin,
Director -
Joerg C Laukien,
10% owner -
Michael Gunnar Knell,
Chief Accounting Officer -
Brenda J Furlong,
Director -
Wolf Dieter Emmerich,
Director -
Taylor Crouch,
Director -
Bob Rosenthal,
-
Laura Francis,
Chief Financial Officer -
John Hulburt,
Dir. of Audit /SEC Compliance -
Martin Haase,
Senior Vice President -
Thomas Werner Bachmann,
President Bruker BioSpin Group -
Charles F Jr Wagner,
Director -
Bernhard Wangler,
Director -
Bernd Gewiese,
President, Bruker BioSpin Corp -
Werner Maas,
President, Bruker BioSpin Corp -
Tony Werner Keller,
Director -
Brian P Monahan,
Corporate Controller -
Dirk D Laukien,
10% owner -
Marc M Laukien,
10% owner -
William J Knight,
Chief Financial Officer -
Richard M Stein,
Secretary -
Isolde Laukien,
10% owner -
Collin J Dsilva,
Director -
Philip Ma,